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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S12112 weeks post-surgery. This increase in disease was not associated with
increased activity. In fact LABORAS revealed that female mice (at 2 weeks
post-surgery) spent more time running and climbing compared to their
male counterparts. Female mice developed painful behaviour at a similar
time post-surgery (12-14 weeks) to males, despite being at an earlier stage
of cartilage damage. We have recently described the molecular response to
acute joint destabilisation which reveals the mechanosensitive induction
of a number of inﬂammatory response genes and potential repair factors.
When we studied this panel of 47 genes in male and female joints we
found that some responded identically in male and female joints, whilst
other were more highly expressed in the female joints. Speciﬁcally, there
was no difference in the levels of Adamts5, IL1b or Mmp13, but TIMP1 (the
metalloproteinase inhibitor), inhibin (a TGFb family member), versican
and Mmp3 were signiﬁcantly higher in female joints.
Conclusions: Pre-menopausal female mice have signiﬁcantly less severe
OA compared to males, and this cannot be attributed to higher levels of
activity in male mice. Nor is it related to increased painful behaviour as
female mice have similar levels as male mice but with less cartilage
damage. The response to acute joint destabilisation reveals an increase in
predominantly matrix, repair and anti-inﬂammatory genes in female mice
compared to males, thereby suggesting that female mice may mount
a more anti-inﬂammatory/repair response compared to males.
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SUSTAINED DELIVERY OF IL-1RA FROM PLGA MICROSPHERES
ATTENUATES IL-1b MEDIATED INFLAMMATION IN A CARTILAGE
TISSUE ANALOG
D.J. Gorth, W. Strutz, B. Mohanraj, R.L. Mauck, L.J. Smith, G.R. Dodge. Univ.
of Pennsylvania, Philadelphia, PA, USA
Purpose: In healthy articular cartilage, chondrocytes maintain equilibrium
between degradation and synthesis. Injury, aging, and misuse can disturb
this balance triggering degeneration characteristic of osteoarthritis.
Current therapeutic options are limited. This study evaluated a novel
therapeutic that targets a cause of degradation, inﬂammatory cytokines
using a cartilage tissue analog (CTA). Using IL-1ra delivered by poly(lactic-
co-glycolic acid) (PLGA) microspheres (MS) our therapeutic approach
mitigates IL-1b’s deleterious effects on cartilage.
Methods: Microsphere Fabrication and Release Kinetics: PLGA MS were
fabricated using the water-oil-water double emulsion technique. Release
kinetics were determined in PBS under agitation at 37C. Over the course
of 5 weeks, supernatant was collected and IL-1ra content was quantiﬁed
using the bicinchoninic acid assay. Cell Isolation and CTA Fabrication:
Chondrocytes were isolated from juvenile bovine knees. Articular cartilage
was removed and minced, and digested with collagenase. The cell
suspension was ﬁltered and washed. Cells were seeded 1x107 cells/well
into a 96-well plate onto poly (2-hydroxyethyl methacrylate to maintain
their cartilage phenotype then cultured for 10 weeks. Cell Treatment: The
treatment groups were: untreated, 10 ng/ml IL-1b, and 10 ng/ml IL-1b +
500 mg/ml IL-1ra MS. CTAs were harvested after 3 and 6 days of treatment.
The 6-day treatment group included 60% media changes at 3 days, with
additional doses of IL-1b added to the relevant groups. mRNA Levels: RNA
was isolated from the CTAs via two sequential extractions using TRIZOL-
chloroform (n¼6). Reverse transcription was performed on 1 mg of RNA in
a 20 ml volume. Quantitative PCRwas performed to determinemRNA levels
of collagen II, aggrecan, COMP, IL-6, iNOS and ADAMTS4, and normalized to
GAPDH. Nitrite Concentration: Nitrite levels in the mediumwere measured
using the Griess assay. Statistics: Differences between treatment groups
were established using ANOVAs with post-hoc Tukey's tests; p<0.05 was
considered signiﬁcant.
Results: IL-1ra was released from the PLGAMS over the course of 5 weeks.
After a burst release in the ﬁrst hour (20.24.4ng per mg of MS), IL-1ra
release leveled to a linear release from day 2 to day 35 of 0.2 ng per mg of
MS per day (r2¼0.99). DeliveringMS to IL-1b treated CTAs inhibited IL-1b’s
effect. While IL-1b caused a large increase in nitrite concentration simul-
taneous IL-1raMS delivery reduced the increase. After both 3 and 6 days,
CTAs treated with IL-1b had signiﬁcantly higher iNOS, ADAMTS4, and IL-6
mRNA levels compared to untreated CTAs. IL-1b treated CTAs had a cor-
responding decrease in themRNA levels of collagen II, aggrecan and COMP.CTAs treated with both IL-1b and IL-1ra MS had no signiﬁcant differences
compared to the untreated.
ĂConclusions: In this study we showed for the ﬁrst time that sustained
IL1-ra released from PLGA microspheres can effectively inhibit IL-1b
mediated inﬂammation in cartilage. Our results suggest that this inhibition
was effective beyond the initial burst release, extending up to 6 days in the
presence of repeated doses of IL-1b. This study provides the foundation for
developing a novel treatment for osteoarthritis.
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FATTY ACIDS MODULATE DESTRUCTIVE AND INFLAMMATORY
PROCESSES IN OSTEOARTHRITIC CARTILAGE
M. Siawash. Erasmus Med. Ctr., Rotterdam, Netherlands
Purpose: Onset and progression of osteoarthritis (OA) are associated
with obesity. Since not only knee OA but also hand OA is associated with
obesity, it is plausible that next to increased joint loading, systemic
metabolic alterations such as adipose-related inﬂammation might
explain this association. In addition, obesity is correlated with altered
fatty acid proﬁles in serum. Recent studies indicate that n-3 poly
unsaturated fatty acids (PUFA's) such as eicosapentaenoic acid (EPA) and
docosahexaenoic acid (DHA) decrease inﬂammation and n-6 PUFA
arachidonic acid (AA) increases inﬂammation in OA joints. In this study
we aim to investigate whether other fatty acids known to be present in
the knee joint such as linoleic acid (n-6), oleic acid (n-9), and palmitic
acid (saturated) are also able to inﬂuence cartilage and thereby
contribute to processes seen in OA.
Methods: Cartilage was obtained from OA patients undergoing total knee
arthroplasty and either cultured as explants (3 donors) or as chon-
drocytes (2 donors) isolated from the cartilage (passage 3). All were
cultured in DMEM low glucose and 1% ITS with or without 10 ng/ml TNFa
as a pro-inﬂammatory stimulus and in absence or presence of DHA,
linoleic acid, oleic acid or palmitic acid. Concentrations were determined
using mass spectrometry. Analysis of cell cultures included quantiﬁcation
of intracellular lipid deposition using Oil-red-O, lactate hydrogenase
(LDH)-assay for cytotoxicity and gene expression for cyclooxygenase 2
(COX2), matrix metalloproteinase (MMP) 1, 3 and 13 and A Disintegrin
and Metalloproteinase with ThromboSpondin motifs (ADAMTS) 4. Carti-
lage explants were analysed for glycosaminoglycan (GAG) release and
nitric oxide (NO) production. Independent sample T-test was used for all
data analysis.
Results: Culturing chondrocytes in the presence of the fatty acids resulted
in an increase of intracellular lipid deposition as determined with Oil-red-
O staining. This effect was independent of TNFa presence in the culture
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gene expression of cultured chondrocytes in response to TNFa was coun-
teracted by DHA (p<0.05) and oleic acid (p<0.05). MMP1 expression was
also increased in response to TNFa and this effect was counteracted by
oleic acid (p<0.05) and palmitic acid (p<0.05). GAG release by cartilage
explants was decreased when cultured in oleic acid (p<0.05). Gene
expression of MMP3, MMP13 and ADAMTS4 in cell cultures and NO
production by cartilage explants did not signiﬁcantly change in response to
any fatty acid. Exposure of chondrocytes and explants to linoleic acid (n-6)
in absence or presence of TNFa did not inﬂuence any of the parameters
measured.
Conclusions: DHA (n-3), oleic acid (n-9), and palmitic acid (saturated) are
able to counteract some of the effects induced by TNFa in cartilage
explants or chondrocyte cultures. This was already known for DHA, but
reported for the ﬁrst time for oleic acid and palmitic acid.
Since fatty acids inﬂuence inﬂammation and degradation of cartilage, they
can be regarded potential therapeutic targets in OA prevention and
treatment.
Figure1. The effect of fatty acids on COX2 gene expression in chondrocytes
in absence or presence of 10 ng/ml TNFa (n¼6, from 2 donors).
ĂAcknowledgment: This study was performed within the framework of the Dutch Top Institute
Pharma project #T1-213.
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THROMBIN AND PLASMIN INDUCED PROTEOGLYCAN RELEASE IN
HUMAN CARTILAGE IS PAR-DEPENDENT
L. Nieuwenhuizen, R.E. Schutgens, G. Roosendaal, S.C. Mastbergen,
D.H. Biesma, F.P. Lafeber. Univ. Med. Ctr. Utrecht, Utrecht, Netherlands
Purpose: Osteoarthritis (OA) and Rheumatoid Arthrisis (RA) are charac-
terized by degradation of the cartilage. Proteases of the coagulation
cascade and the ﬁbrinolytic system, such as thrombin and plasmin, are
elevated in both plasma and synovial ﬂuid of OA and RA patients and are
able to induce cartilage degradation. Cross-talking between coagulation
and inﬂammation is mediated by protease-activated-receptors (PARs),
which are expressed at increased level in OA and RA cartilage. These
receptors are activated through cleavage by serine proteases, such as
thrombin and plasmin. RNA interference is a process inwhich genes can be
silenced sequence-speciﬁc. This can be invoked by transfection of tissue/
cells with small interfering RNA (siRNA). Our aimwas to study whether the
thrombin- and plasmin-induced cartilage damage in human cartilage was
PAR-dependent.
Methods: Full-thickness OA human articular cartilage tissue was
obtained during total knee surgery. Slices of cartilage were cut asepti-
cally from the articular surface. Within 1 hour of dissection the sliceswere cut into square pieces, weighed aseptically (range, 5.0 to 15.0 mg)
and each sample was individually put into culture. Cartilage was
cultured for 4 days in the presence of different concentrations thrombin
(10, 30, or 100nM), or plasmin (10, 30, or 100nM). In addition, cartilage
was transfected with PAR1-4 small interfering RNA (600nM) or control
siRNA (600nM), and cultured with thrombin (100nM) or plasmin
(100nM). Cartilage matrix turnover, in terms of proteoglycan release,
was determined at day 4. To investigate the silencing effect of the siRNA
transfection, cartilage RNA was extracted and PAR1-4 mRNA expression
was analyzed with RT-PCR.
Results: Thrombin and plasmin increased proteoglycan release in human
cartilage in a dose-dependent and statistically signiﬁcant manner (500%
for thrombin at 100nM; 217% for plasmin at 100nM). Thrombin- and
plasmin-induced proteoglycan release was statistically signiﬁcant reduced
with PAR1-4 siRNA (60% for thrombin at 100nM; 54% for plasmin at
100nM). Control siRNA failed to reduce thrombin- and plasmin-induced
proteoglycan release. Transfectionwith PAR1-4 siRNA resulted in complete
suppression of PAR1-4 mRNA expression, whereas no effect of control
siRNA on PAR1-4 mRNA expression was noted.
Conclusions: These results demonstrate for the ﬁrst time that thrombin
and plasmin-induced proteoglycan release in human cartilage is PAR-
dependent and offer promise for the use of siRNA as a new strategy for
therapeutic intervention in OA and RA.
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BONE SIALOPROTEIN : A KEY MEDIATOR OF THE ANGIOGENIC ACTIVITY
OF HYPERTROPHIC OSTEOARTHRITIC CHONDROCYTES
L. Pesesse 1, C. Sanchez 1, C. Baudouin 2, P. Msika 2, Y. Henrotin 1. 1Univ. of
Liege, Liege, Belgium; 2 Laboratoires ExpanSci., IRD Direction, Epernon, France
Purpose: Hypertrophic differentiation of chondrocytes in osteoarthritis
(OA) is a pathological process leading to vascularization and mineraliza-
tion of the cartilage. The pathogenesis of OA is thought to reiterate changes
that occur during endochondral ossiﬁcation in which angiogenesis is
required to initiate chondrocyte hypertrophic differentiation. We previ-
ously demonstrated that Bone Sialoprotein (BSP) production is associated
with chondrocyte hypertrophy and the severity of osteoarthritic lesions. In
this work, we investigated the impact of hypertrophic differentiation on
the chondrocytes capacity to promote vascularization. We also speculated
that BSP is a key mediator of cartilage vascularization.
Methods: In alginate beads, OA chondrocytes cultured in the presence of
serum undergo hypertrophic differentiation in long-term culture. Using
this model, we tested the effects of hypertrophic chondrocytes condi-
tioned medium after 24 hours serum deprivation on the invasion and
migration of endothelial cells using two different models : the real-time
follow-up of the cells performed with the xCELLigence system (Roche)
and high-end microscopic analysis of living endothelial cells in a wound
healing assay. We also studied BSP gene expression (by RT-PCR)
and production (by western blot) during chondrocyte hypertrophic
differentiation. The effects of IL-1b (170 pg/ml) and TNFa (25 ng/ml) were
tested on the synthesis of BSP by hypertrophic chondrocytes. These
cytokines were added to the culture medium before (day 7) or after
(day 21) hypertrophic phenotype was reached. Finally, the effect of
increased concentration of recombinant BSP (25 ng/ml to 400 ng/ml) on
the production of a proangiogenic factor, interleukin-8 (IL8) and an
anti-angiogenic factor, thrombospondin-1 (TSP1) was studied by
immunoassays.
Results: Hypertrophic OA chondrocytes conditionned medium showed
a higher stimulating effect on endothelial cells migration and invasion
than serum-containing medium (positive control). We demonstrated that
BSP gene expression and protein productionwere associated with markers
of hypertrophy collagen type 10 (COL X), alkaline phosphatase (AP),
nucleoside triphosphate pyrophosphohydrolase (NTPPPH) in OA but this
association was not observed in normal chondrocyte cultures. IL-1b or
TNFa in the culture medium decreased gene expression of BSP when
added at day 7 or at day 21 (p<0.05). In the same manner, both cytokines
